Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Romano

Showing results (71-80 of 165) with videos related to

Pageof 17
Sort By:
Frontiers in Oncology|March 3, 2023
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccineGiuseppe A Palumbo, Daniela Cambria, Enrico La Spina, et al.
Biomolecules|December 23, 2023
Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological CancersSebastiano Giallongo, Andrea Duminuco, Ilaria Dulcamare, et al.
Biomed Research International|June 27, 2014
Salvage therapy of multiple myeloma: the new generation drugsAlessandra Romano, Concetta Conticello, Maide Cavalli, et al.
Frontiers in Oncology|April 26, 2021
IDH1/IDH2 Inhibition in Acute Myeloid LeukemiaClaudio Cerchione, Alessandra Romano, Naval Daver, et al.
World Journal of Gastroenterology|October 4, 2014
Endoscopic features of gastro-intestinal lymphomas: from diagnosis to follow-upCalogero Vetro, Alessandra Romano, Irene Amico, et al.
Frontiers in Pharmacology|May 12, 2017
Proteomic Analysis Reveals Autophagy as Pro-Survival Pathway Elicited by Long-Term Exposure with 5-Azacitidine in High-Risk MyelodysplasiaAlessandra Romano, Cesarina Giallongo, Piera La Cava, et al.
Frontiers in Pharmacology|November 4, 2015
Bortezomib modulates CHIT1 and YKL40 in monocyte-derived osteoclast and in myeloma cellsDaniele Tibullo, Michelino Di Rosa, Cesarina Giallongo, et al.
Vaccines|February 26, 2025
Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center ExperienceAndrea Duminuco, Anna Bulla, Rosamaria Rosso, et al.
Frontiers in Oncology|April 17, 2023
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimabAndrea Duminuco, Alessandra Romano, Dario Leotta, et al.
Hematology Reports|September 23, 2024
IgG-k/IgG-λ Para-Osseous Plasmacytoma Relapsed as Soft-Tissue Plasmacytoma with IgA-k Immunophenotype: A Case Report and Review of the Literature on Related Biochemical AspectsManlio Fazio, Chiara Maria Catena Sorbello, Vittorio Del Fabro, et al.
Pageof 17

Showing results (71-80 of 165) with videos related to

Sort By:
Pageof 17
Frontiers in Oncology|March 3, 2023
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccineGiuseppe A Palumbo, Daniela Cambria, Enrico La Spina, et al.
Biomolecules|December 23, 2023
Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological CancersSebastiano Giallongo, Andrea Duminuco, Ilaria Dulcamare, et al.
Biomed Research International|June 27, 2014
Salvage therapy of multiple myeloma: the new generation drugsAlessandra Romano, Concetta Conticello, Maide Cavalli, et al.
Frontiers in Oncology|April 26, 2021
IDH1/IDH2 Inhibition in Acute Myeloid LeukemiaClaudio Cerchione, Alessandra Romano, Naval Daver, et al.
World Journal of Gastroenterology|October 4, 2014
Endoscopic features of gastro-intestinal lymphomas: from diagnosis to follow-upCalogero Vetro, Alessandra Romano, Irene Amico, et al.
Frontiers in Pharmacology|May 12, 2017
Proteomic Analysis Reveals Autophagy as Pro-Survival Pathway Elicited by Long-Term Exposure with 5-Azacitidine in High-Risk MyelodysplasiaAlessandra Romano, Cesarina Giallongo, Piera La Cava, et al.
Frontiers in Pharmacology|November 4, 2015
Bortezomib modulates CHIT1 and YKL40 in monocyte-derived osteoclast and in myeloma cellsDaniele Tibullo, Michelino Di Rosa, Cesarina Giallongo, et al.
Vaccines|February 26, 2025
Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center ExperienceAndrea Duminuco, Anna Bulla, Rosamaria Rosso, et al.
Frontiers in Oncology|April 17, 2023
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimabAndrea Duminuco, Alessandra Romano, Dario Leotta, et al.
Hematology Reports|September 23, 2024
IgG-k/IgG-λ Para-Osseous Plasmacytoma Relapsed as Soft-Tissue Plasmacytoma with IgA-k Immunophenotype: A Case Report and Review of the Literature on Related Biochemical AspectsManlio Fazio, Chiara Maria Catena Sorbello, Vittorio Del Fabro, et al.
Pageof 17